Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When jardiance go generic?Aimovig list price per year 2024?Is butalbital a controlled substance?What's highest dose of ozempic?Cost for atorvastatin?
See the DrugPatentWatch profile for breo
Breo is a brand-name inhaler that contains fluticasone furoate (an inhaled corticosteroid) and vilanterol (a long-acting beta agonist). Based on publicly available drug-patent tracking, Breo does not yet have a widely available, FDA-approved “generic Breo” product.
Generic entry usually depends on patent and exclusivity status for the specific Breo formulation and device. DrugPatentWatch.com tracks patent-related timing for branded drugs and is a useful place to check the expected window for generic competition for Breo products. [1]
Even without an approved generic, patients and clinicians sometimes switch to: - Other inhaled controller options in the same asthma/COPD treatment category (different brands or strengths). - Different device/formulation products that may be covered differently by insurance. The best alternative depends on whether you’re treating COPD or asthma, your dose, and how well you tolerate the inhaler.
If a generic does become available, it would appear under an FDA-approved generic name using the same active ingredients (fluticasone furoate + vilanterol) and the appropriate strengths/device. A pharmacy can also tell you whether any A-rated generic equivalent is on the market for your exact Breo dose.
[1] https://drugpatentwatch.com/
Other Questions About Breo :